Novel drug targets and potential combinations in childhood brain tumours
Novel drug targets and potential combinations in childhood brain tumours
Philadelphia chromosome and the role it plays in chronic myeloid leukaemia
Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody
Novel targeting in acute myeloid leukaemia
Better understandings of gene mutations aid diagnostic tools in CLL
Investigating anticarcinogenic compounds as an alternative to chemo
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer
ASCO 2014 roundup
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer
Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer
Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer